Cancer Genetics, Inc. (NASDAQ: CGIX) Soars 256% After Reporting Third Quarter 2019 Financial Results, and Strategy Updates
Cancer Genetics, Inc. (NASDAQ: CGIX) is engaged as a preclinical oncology, drug discovery, and other related services. This includes developing ...